Meeker David P — SEC insider filings

SEC reporting owner CIK 1385155. 23 insider filings on record with FilingPulse; latest filed 2026-09-14.

Transaction summary — filings shown

Covers all 23 filings on record, filed 2020-11-19 to 2026-09-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
RHYTHM PHARMACEUTICALS, INC. (RYTM)President and CEO, Director131 leg · 10,000 sh · $201,71311 legs · 157,649 sh · $10,772,04726
Trevi Therapeutics, Inc. (TRVI)Director8—1 leg · 4,555 sh · $13,3539
MyoKardia, Inc. (MYOK)Director1——6
Kardigan, Inc. (KARD)Director1——1

Insider filings — Meeker David P

FiledFormIssuerReported transactionsSource
2026-09-144RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 50,000 @ $6.05 · Sale (S): 6,439 @ $101.75 · Sale (S): 30,746 @ $102.35 · Sale (S): 8,698 @ $103.43 · Sale (S): 1,817 @ $104.55 · Sale (S): 2,300 @ $105.19 · +1 moreEDGAR
2026-06-224Kardigan, Inc. (KARD)Grant/award (A): 20,706 @ $0EDGAR
2026-06-044Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2026-02-134RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 71,900 (derivative) @ $0 · Grant/award (A): 107,850 (derivative) @ $0EDGAR
2026-02-034RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 68,713 · Tax withholding (F): 31,522 @ $108.99 · Option exercise (M): 14,125 (derivative) @ $0 · Option exercise (M): 21,250 (derivative) @ $0 · Option exercise (M): 33,338 (derivative) @ $0EDGAR
2025-06-134Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 45,000 (derivative) @ $0EDGAR
2025-06-054RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 43,620 @ $4.59 · Sale (S): 43,346 @ $65.04 · Sale (S): 274 @ $65.60 · Option exercise (M): 43,620 (derivative) @ $0EDGAR
2025-02-194RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 21,250 · Sale (S): 9,896 @ $57.22 · Grant/award (A): 133,350 (derivative) @ $0 · Grant/award (A): 200,000 (derivative) @ $0 · Option exercise (M): 21,250 (derivative) @ $0EDGAR
2025-02-044RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 14,125 · Sale (S): 4,278 @ $59.43 · Option exercise (M): 14,125 (derivative) @ $0EDGAR
2024-08-294Trevi Therapeutics, Inc. (TRVI)Option exercise (M): 4,555 @ $1.43 · Sale (S): 4,555 @ $2.93 · Option exercise (M): 4,555 (derivative) @ $0EDGAR
2024-06-144Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2024-03-194RHYTHM PHARMACEUTICALS, INC. (RYTM)Sale (S): 45,494 @ $39.22EDGAR
2024-02-214RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 99,000 @ $0 · Grant/award (A): 85,000 (derivative) @ $0 · Grant/award (A): 259,000 (derivative) @ $0EDGAR
2024-02-054RHYTHM PHARMACEUTICALS, INC. (RYTM)Option exercise (M): 14,125 · Sale (S): 4,361 @ $45.06 · Option exercise (M): 14,125 (derivative) @ $0EDGAR
2023-06-304Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2023-02-034RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 56,500 (derivative) @ $0 · Grant/award (A): 229,600 (derivative) @ $0EDGAR
2022-07-014/ATrevi Therapeutics, Inc. (TRVI)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-06-234Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2022-02-114RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 510,000 (derivative) @ $0EDGAR
2021-06-174Trevi Therapeutics, Inc. (TRVI)Grant/award (A): 20,000 (derivative) @ $0EDGAR
2021-03-314RHYTHM PHARMACEUTICALS, INC. (RYTM)Purchase (P): 10,000 @ $20.17EDGAR
2021-02-164RHYTHM PHARMACEUTICALS, INC. (RYTM)Grant/award (A): 220,000 (derivative) @ $0EDGAR
2020-11-194MyoKardia, Inc. (MYOK)Code (U): 4,100 · Disposition to issuer (D): 22,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 11,000 (derivative) · Disposition to issuer (D): 6,600 (derivative) · Disposition to issuer (D): 3,000 (derivative)EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1385155 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs